Advertisement

Topics

Pharmatech Oncology, Inc. Company Profile

12:13 EDT 24th September 2018 | BioPortfolio


News Articles [442 Associated News Articles listed on BioPortfolio]

Bring Your Oncology Drug To Market Quicker: Think Patients First

New cancer drugs take too much time and cost too much money to bring to market. The time to peak sales for products in development can be shortened by reducing the time to complete patient enrollmen...

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

Published date:  03/07/2018 Summary:  Novo Nordisk Pharmatech A/S enters a distrib...

Wuxi Pharmatech Cayman Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Wuxi Pharmatech Cayman Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Wuxi Pharmatech Cayman Inc Mergers Acquisitions MA, Partnerships Alliances and ...

Pharmatech Appoints New Chief Financial Officer

Pharmatech Associates announces the expansion of its executive management team with the addition of Ms. Michaela Mueller as the Chief Financial Officer and Corporate Secret...

Back to the future? The resurgence of combination drug products

Drugmakers can greatly profit from developing a combination drug, but must address manufacturing and regulatory challenges in the early development stage, says Pharmatech Associates.

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Analysis of oncology pipeline

Oncology research, which includes the medical, radiation, and surgical fields, is always ongoing. Therefore, the oncology pipeline is a key...Read More... The post Analysis of oncology pipeline appear...

Axel Hoos, GSK: Focusing on immuno-oncology and cancer epigenetics

GSK has had a recent change in Oncology after recently divesting their marketed oncology products to Novartis whilst retaining their R&D pipeline. During BIO 2015, Axel Hoos, VP Oncology R&D at GSK ex...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Tandem dha [US Pharmaceutical Corporation]

see all prescribing information for Tandem DHA

Carboplatin [Bedford Laboratories]

CARBOplatin Injection

Carboplatin injection [Sun Pharma Global Inc.]

Carboplatin Injection

Carboplatin [Bedford Laboratories]

CARBOplatin for Injection USP

PubMed Articles [1218 Associated PubMed Articles listed on BioPortfolio]

Nonspecialty Nurse Education: Evaluation of the Oncology Intensives Initiative, an Oncology Curriculum to Improve Patient Care.

A community hospital combined its medical and surgical patients with cancer on one unit, which resulted in nurses not trained in oncology caring for this patient population.

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey.

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

As many biosimilars come to market in the next several years, their use in oncology will play an important role in the future care of patients with cancer. ASCO is committed to providing education and...

Clinical Trials [530 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Integrative Care Training Program for Nurses on Supportive Cancer Care

The integration of complementary medicine in supportive and palliative cancer care (i.e., Integrative Oncology) is becoming more prevalent in many of the leading oncology centers in Israel...

Companies [745 Associated Companies listed on BioPortfolio]

Pharmatech, Inc.

Pharmatech, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech provides services of a Site Management ...

Pharmatech Oncology, Inc.

Pharmatech Associates, Inc.

Pharmatech Associates, Inc. (founded 1995) consults to the pharmaceutical, biotech, medical device manufacturing and other regulated life sciences industries. Headquartered in the...

Pharmatech Associates

Pharmatech Associates, Inc. (founded in 1995) consults to the pharmaceutical, biotech, medical device manufacturing and other regulated life sciences industries. Headquartered in ...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused co...

More Information about "Pharmatech Oncology, Inc." on BioPortfolio

We have published hundreds of Pharmatech Oncology, Inc. news stories on BioPortfolio along with dozens of Pharmatech Oncology, Inc. Clinical Trials and PubMed Articles about Pharmatech Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmatech Oncology, Inc. Companies in our database. You can also find out about relevant Pharmatech Oncology, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record